![[LSF] Life-Sciences-France.com - The French Life Sciences Web Portal](/images/basics/lsf-life-sciences-france-portal-logo.svg){kind=logo}
Advertisement
Persons > All
France
Monaco
Central France
Eastern France
Northern France
Paris (region)
Southern France
Western France
Find below all kinds of persons from France & Monaco.Total search results: 2420 | Ordered by Person (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 
  Person |
 Position |
Organisation (Group) |
Region |
|---|---|---|---|
| Zwighaft, Ziv (Ambrosia Bio 202206 CEO + Co-Founder) | Chief Executive Officer (CEO) | Ambrosia Bio (IL) | Israel_o |
| Zumbrum, Michael (AllPure Technologies 201404 President) | President/Director/Head Business Group/Unit/Division | Sartorius (Group) | Pennsylvania (federal state) |
| Zuliani, Vincent (GenoSafe 201611 Business Development Director) | Business Development Manager / Strategy Manager | GenoSafe SAS | Île-de-France (region) |
| Zoro, Barney (Sartorius 201803 ambr Product Manager at SSB) | Product Manager (personnel) | Sartorius (Group) | Niedersachsen (federal state) |
| Zoller, Jessica (France (govt) 202004 Life Science Analyst at Bpifrance) | Analyst (Financial / Industry) | France (govt) | Île-de-France (region) |
| Znaty, David (ScreenCell 201205 CEO) | Chief Executive Officer (CEO) | ScreenCell (FR) | Île-de-France (region) |
| Zippelius, Peter (Leonard Green & Partners 201904 Partner) | Partner (venture partner) | Leonard Green & Partners L.P. (LGP) | California (federal state) |
| Zins, Antoine (Eurazeo 202004 Investment Manager at Idinvest Partners) | Investment Manager | Eurazeo (Group) | Île-de-France (region) |
| Zilliox, Patricia (Eyevensys 201712– CEO joined board 201605 before Foundation Fighting Blindness + Alcon) | Chief Executive Officer (CEO) | Eyevensys (Group) | Île-de-France (region) |
| Zhukovsky, Eugene (Biomunex 201510– CSO before Affimed + Boehringer Ingelheim Pharmaceuticals + Xencor) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Biomunex Pharmaceuticals SASU | Île-de-France (region) |
| Zhou, Li (TxCell 201610– VP Cell Engineerung before ZMKS + Novartis Biologics Center MA + MGH + Cereon Genomics) | Researcher (industry) | TxCell S.A. (Euronext Paris: TXCL) | Provence-Alpes-Côte d’Azur (region) |
| Zhong, Weidong (Terns Pharmaceuticals 201906 CEO) | Chief Executive Officer (CEO) | Terns Pharmaceuticals, Inc. | California (federal state) |
| Zeyer, Denis (Novalix 201011 CEO) | Chief Executive Officer (CEO) | Novalix (Group) | Grand Est (Great East) (region) |
| Zettlmeissl, Gerd (Intercell 2005–201105 CEO before COO since 2001 before Chiron Behring before Behringwerke) | Chief Executive Officer (CEO) | Valneva (Group) | Wien (state) |
| Zerhouni, Elias A. (Sanofi-Aventis 201101– President Global RnD before NIH Director 2002–2008) | Research & Development Manager | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Zenker, Matthias (GAIA 201702 Business Development) | Business Development Manager / Strategy Manager | GAIA AG | Hamburg (federal state) |
| Zehnder, Alexander (CureVac 202304– CEO before Sanofi + Roche/Genetech) | Chief Executive Officer (CEO) | CureVac (Group) | Baden-Württemberg (federal state) |
| Zbinden, Laurent (MedXCell 202203 CEO) | Chief Executive Officer (CEO) | MedXCell (Group) | Région Lémanique (region) |
| Zapico, David A. (AMETEK 201608 CEO) | Chief Executive Officer (CEO) | AMETEK (Group) | Pennsylvania (federal state) |
| Zakrzewski, Joseph S. (Xcellerex 200705 CEO) | Chief Executive Officer (CEO) | Xcellerex LLC | Massachusetts (federal state) |
| Zacho, Helle (Dutscher 202304– CEO of AH Diagnostics joined as CSO in 2017 before Novo Nordisk) | Chief Executive Officer (CEO) | Dutscher (DD) (Group) | Denmark_o |
| Yvon, Pascal (S-Biomedic 202208– SVP Commercial Strategy + Sales before Croda Inc) | Sales Manager / Marketing Manager | Beiersdorf (Group) | Flanders (Flemish region) |
| Yusupova, Gulnara (CNRS 201911 Research Director at IGBMC in Strasbourg) | Researcher (university / research institute) | University of Strasbourg | Grand Est (Great East) (region) |
| Yusupov, Marat (CNRS 201911 Research Director at IGBMC in Strasbourg) | Researcher (university / research institute) | University of Strasbourg | Grand Est (Great East) (region) |
| Yu, Yuexin (Andera Partners 202201 Investment Director at Andera Life Sciences) | Investment Manager | Andera Partners (FR) | Île-de-France (region) |
| Yu, Michael (Innovent Biologics 202208 CEO + Founder) | n. a. | ||
| Yu, Frank (Ally Bridge Group 201702 CEO + CIO + Founder) | Chief Executive Officer (CEO) | Ally Bridge Group (ABG) | Hong Kong (province) |
| Young, Steve (200607 MDL Director Content Strategy) | n. a. | Dassault Systèmes (3DS) (Group) | California (federal state) |
| Young, Joshua (Bruker 201301– VP Investor Relations before Merck KGA + Millipore LEFT BEFORE 7/16) | Public Relations Manager / Investor Relations Manager | Bruker (Group) | Massachusetts (federal state) |
| You, Angie (Amunix Pharmaceuticals 202103 CFO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | California (federal state) |
| Yoder, Stephen S. (Steve) (Pieris 201001– CEO before MorphoSys Head Licensing + IP) | Chief Executive Officer (CEO) | Pieris (Group) | Bayern (federal state) |
| Yerganian, Syrane (Strammer 201704 CFO) | Chief Executive Officer (CEO) | Strammer (Group) | Île-de-France (region) |
| Ybert, Thomas (DNA Script 201709 CEO + Co-Founder) | Chief Executive Officer (CEO) | DNA Script (Group) | Île-de-France (region) |
| Yasri, Aziz (OriBase Pharma 201403 CEO + Founder) | Chief Executive Officer (CEO) | PPF Group (Group) | Occitanie (Occitania) (region) |
| Yao, Zhizhong (Joel) (Sofinnova 202312 Partner in Biovelocita initiative) | Partner (venture partner) | ||
| Yang, Jerry (HCVC 202211 General Partner) | General Partner (venture partner) | HCVC (Hardware Club VC) | Île-de-France (region) |
| Yancopoulos, George D. (Regeneron 200703 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Regeneron (Group) | New York (federal state) |
| Yanai, Shlomo (Teva 200706 President + CEO) | Chief Executive Officer (CEO) | Teva (Group) | Israel_o |
| Yamanaka, Shinya (Univ Kyoto 201004– Director of CiRA + Nobel Laureate 2012) | Professor | University of Kyoto (Kyoto University) | Kinki (region) |
| Xia, Ning (Chemical.AI 202101 CEO) | Chief Executive Officer (CEO) | Chemical.AI (Wuhan Zhihua Technology) (Group) | Hubei (Hupeh) (province) |
| Wuurman, Bart (Apaxen 202011– CEO before Lyramid + Lanthio Pharma + AM-Pharma + De Novo Pharma + Antisoma) | Chief Executive Officer (CEO) | Apaxen S.A. | Wallonia (region) |
| Wurm, Florian (ExcellGene 200905 CSO + founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | ExcellGene S.A. | Région Lémanique (region) |
| Wright, Fraser (Yposkesi 201807– Senior Advisor before co-founder + CTO of Spark Therapeutics + Avigen) | Consultant (economic/technology) | SK Group (Group) | Île-de-France (region) |
| Wren, John (Omnicom 201307 CEO) | Chief Executive Officer (CEO) | Omnicom (Group) | New York (federal state) |
| Woodman, Rob (Panakès Partners 202109– Partner to lead biotech team before Takeda Ventures + Imperial Innovations) | Partner (venture partner) | Panakès Partners (Group) | Lombardia (Lombardy) |
| Wood, Michael (LifeSci Advisors 2014) | Public Relations Manager / Investor Relations Manager | LifeSci (Group) | New York (federal state) |
| Wood, Clive R. (Boehringer 201403– SVP Discovery Research before Bayer HealthCare + Dyax) | President/Director/Head Business Group/Unit/Division | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
| Wood, Christopher B. (Chris) (NuCana Biomed 2008– Executive Chair + Co-founder before Bioenvision 1999–2007 CEO) | Chief Executive Officer (CEO) | NuCana plc (Nasdaq: NCNA) | Scotland |
| Wolikow, Nicolas (Cure51 202403 CEO + Co-Founder) | Chief Executive Officer (CEO) | Cure51 SAS | Île-de-France (region) |
| Woler, Charles (Neuro3d 200504 CEO) | Chief Executive Officer (CEO) | Evotec (Group) | Grand Est (Great East) (region) |
| Woler, Charles (Biomnis 201210– CEO before Endotis Pharma CEO) | Chief Executive Officer (CEO) | Eurofins (Group) | Auvergne-Rhône-Alpes (region) |
| Woker, Mathias (AMSilk 201210– CBO located in Boston before Graffinity 200603 Senior VP BusDev US) | Business Development Manager / Strategy Manager | AMSilk GmbH | Bayern (federal state) |
| Wojczewski, Christian (Evotec 202407– CEO before Mediq + Linde + McKinsey) | Chief Executive Officer (CEO) | Evotec (Group) | Hamburg (federal state) |
| Woiwode, Tom (Versant Ventures 201404 before Synosis + Xenoport) | Venture Partner | Versant Ventures | California (federal state) |
| Woerle, Hans-Juergen (Boehringer 201706 Global VP Medicine) | Chief Medical Officer (CMO) | Nestlé (Group) | Région Lémanique (region) |
| Witz, Pascale (Sanofi 201307–201605 EVP before GE Healthcare + Becton Dickinson LEFT 6/16) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Witte, Sariette (Alentis Therapeutics 202309 Head of Communications) | Public Relations Manager / Investor Relations Manager | Alentis Therapeutics AG | Northwestern Switzerland (region) |
| Wispenninckx, Jérome (Imlab 202205 CEO) | Chief Executive Officer (CEO) | Imlab (Group) | Belgium_o |
| Wisniewski, Raphaël (Andera Partners 202110 formerly LCF Rothschild at Edmond de Rothschild Investment Partners) | Partner (venture partner) | Andera Partners (FR) | Île-de-France (region) |
| Windhab, Norbert | n. a. | Sanofi (Group) [since May 2011] | Hessen (Hesse) (federal state) |
| Wilson, Ian (ImaginAb 201902– CEO joined 201802 as COO before Edinburgh Molecular Imaging + Xstrahl Ltd) | Chief Executive Officer (CEO) | ImaginAb Inc. | California (federal state) |
| Wilson, Dominic (Bryan Garnier 201709– Managing Director at European Healthcare division before Zeus Capital + Nomura) | Managing Director | Bryan, Garnier & Co., Ltd. | Greater London (region) |
| WIlliams, Jeff (Clinipace 201504 CEO) | Chief Executive Officer (CEO) | Clinipace (Group) | North Carolina (federal state) |
| Williams, Dave (Sanofi Pasteur 200702 CEO) | Chief Executive Officer (CEO) | Sanofi (Group) [since May 2011] | |
| Wilking, Karsten (Polyplus-transfection 2017– CEO before Life Technologies/Applied Bisystems/Invitrogen) | Managing Director | Sartorius (Group) | Grand Est (Great East) (region) |
| Wiest, Kajo (Humedics 202302 Manager Finance + Controlling) | Chief Financial Officer (CFO) | Humedics GmbH | Brandenburg (federal state) |
| Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) | Managing Director | Eurofins (Group) | Bayern (federal state) |
| Wicki, Andreas (HBM Healthcare Investments 201402 CEO) | Chief Executive Officer (CEO) | HBM (Group) | Central Switzerland (region) |
| Wicke, Ilka (Boehringer 201203 Director at Boehringer Ingelheim Venture Fund) | Investment Manager | Boehringer Ingelheim (Group) | Rheinland-Pfalz (federal state) |
| Whittingham, Jerel (Myconostica 200804 CEO) | Chief Executive Officer (CEO) | Novacyt (Group) | North West England (region) |
| White, Randy (Adnavance 200802– CEO before Nanogen CEO + Xenomics CEO before Executive VP American Medical Laboratories) | Chief Executive Officer (CEO) | Adnavance Technologies Inc. | British Columbia |
| White, Janet (Lonza 201109 Head Development Services) | President/Director/Head Business Group/Unit/Division | Lonza (Group) | Northwestern Switzerland (region) |
| Whelan, James P. (bioMérieux 201101– EVP Commercial Services before Magellan + ESA Biosciences before LabCorp + Fisher) | Business Manager | Mérieux (Group) | Auvergne-Rhône-Alpes (region) |
| Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland) | Public Relations Manager / Investor Relations Manager | Akampion | Hamburg (federal state) |
| Werner, Thomas (Board Member of several companies before GSK SVP) | Board member, non-executive | GSK (Group) | Greater London (region) |
| Wermuth, Camille G. (Prestwick Chemical 200411 CSO + founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Bionomics (Group) | Grand Est (Great East) (region) |
| Wentworth, James (Transgene 202401– CBO before Adaptimmune + inVentiv Health + Shire + ViroPharma) | Chief Business Officer (CBO) | Mérieux (Group) | Grand Est (Great East) (region) |
| Wencker, Dominique (Dutscher 202108 CEO) | Chief Executive Officer (CEO) | Dutscher (DD) (Group) | Grand Est (Great East) (region) |
| Welsh, Chris (Consilium Strategic Communications 201707) | Public Relations Manager / Investor Relations Manager | ICR (Group) | Greater London (region) |
| Welch, William J. (Bill) (Sequenom 201101– SVP Diagnostics before Monogram 200803– before Dade Behring before La Jolla) | Sales Manager / Marketing Manager | LabCorp (Group) | California (federal state) |
| Weiss, Mario (GAIA 201702 CEO + Founder) | Chief Executive Officer (CEO) | GAIA AG | Hamburg (federal state) |
| Weir, Neil (Sitryx Therapeutics 201804– CEO before UCB SVP Discovery) | Chief Executive Officer (CEO) | Sitryx Therapeutics Ltd. | South East England (region) |
| Weiner, Aaron (Coatue Management 202110 Managing Director + Head of Healthcare) | Managing Director | Coatue Management | |
| Weinberg, Serge (Sanofi 201906 Board Chairman) | Board member, non-executive | Sanofi (Group) [since May 2011] | Île-de-France (region) |
| Weinand, Dieter (Sanofi 201811– Head Primary Care Unit before Bayer + Otsuka + Pfzer + BMS) | President/Director/Head Business Group/Unit/Division | Sanofi (Group) [since May 2011] | |
| Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) | Chief Financial Officer (CFO) | Eurofins (Group) | Pays de la Loire (region) |
| Waymel, Bertrand (Novasep 201505– promoted to Group Human Resources Director joined Novasep in 2012) | Human Resources Manager | Novasep (Group) | Grand Est (Great East) (region) |
| Wattin, Martin (Contur Software AB 201105 CEO) | Chief Executive Officer (CEO) | Dassault Systèmes (3DS) (Group) | Stockholm (region) |
| Watt, Alan (NodThera Ltd 201806 CSO + acting CEO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | NodThera Ltd. | East of England (region) |
| Ward, Nagib (Deinove 201307– VP Business Development before Novozymes North America Inc) | Business Development Manager / Strategy Manager | Deinove S.A. (Euronext Growth: ALDEI.PA) | Île-de-France (region) |
| Wanner, Sarah-Christine (Bayer 202003 External Innovation + Partnering) | n. a. | Bayer (Group) | Berlin (federal state) |
| Wang, Haixang (APG Bio (CN) 201706 CEO) | Sales Manager / Marketing Manager | Shanghai (province) | |
| Wang, Daniel D. (TUS-Holdings 202002 CEO of Tuspark Europe) | Managing Partner (investment firm) | TUS-Holdings (Tuspark) (Group) | Europe_ooo |
| Wang, Bing C. (Cellectis 202202– CFO before Refuge Biotechnologies + Barclays Capital + Citigroup Global Markets) | Chief Financial Officer (CFO) | Cellectis (Group) | Île-de-France (region) |
| Walter, Monika (Hyglos 2010 Manager Operations) | Chief Operating Officer (COO) | Mérieux (Group) | Bayern (federal state) |
| Walsh, Christopher (Harvard Univ 200603 Professor + co-founder Genzyme + Vicuron Pharmaceuticals) | Professor | Harvard University | Massachusetts (federal state) |
| Walrafen, Pierre (Scipio Bioscience 201711 CEO) | Chief Executive Officer (CEO) | Scipio Bioscience SAS | Île-de-France (region) |
| Walrafen, Luc (Scipio Bioscience 202206 CFO) | Chief Financial Officer (CFO) | Scipio Bioscience SAS | Île-de-France (region) |
| Walmsley, Emma (GSK 201704– CEO before CEO of GSK Consumer Healthcare division joined GSK 2010 from L’Oréal) | Chief Executive Officer (CEO) | GSK (Group) | United Kingdom (state/region unspecified) |
| Walls, Matthew (EpiStem 200704 CEO) | Chief Executive Officer (CEO) | Genedrive (Group) | North West England (region) |
Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
